
X4 Pharmaceuticals (XFOR) Enterprise Value
Price: $0.19
Market Cap: $33.13M
Avg Volume: 3.32M
Market Cap: $33.13M
Avg Volume: 3.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to X4 Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 169.89M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 147.50M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $0.7336, with 201.06M shares outstanding.
- The company has 55.70M in cash and cash equivalents and 78.09M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$169.89M
Market Cap
$147.50M
Total Debt
$78.09M
Cash and Equivalents
$55.70M
Historical Enterprise Value
X4 Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
---|---|---|---|---|---|---|---|
December 31, 2024 | $169.89M | 47.43% | $0.7336 | 201.06M | $147.50M | $55.70M | $78.09M |
September 30, 2024 | $115.23M | 134.45% | $0.6693 | 200.87M | $134.44M | $97.41M | $78.20M |
June 30, 2024 | $49.15M | -82.43% | $0.5894 | 200.44M | $118.14M | $147.22M | $78.23M |
March 31, 2024 | $279.77M | 122.96% | $1.41 | 199.99M | $281.99M | $60.49M | $58.27M |
December 31, 2023 | $125.48M | -11.27% | $0.8385 | 198.77M | $166.67M | $99.47M | $58.28M |
September 30, 2023 | $141.42M | -37.92% | $1.09 | 196.99M | $214.72M | $131.58M | $58.29M |
June 30, 2023 | $227.80M | 730.30% | $1.94 | 168.74M | $327.35M | $136.43M | $36.87M |
March 31, 2023 | $27.44M | -37.06% | $0.87 | 145.97M | $126.99M | $136.43M | $36.87M |
December 31, 2022 | $43.59M | -51.03% | $0.993 | 100.77M | $100.06M | $93.41M | $36.93M |
September 30, 2022 | $89.01M | 253.34% | $1.71 | 100.77M | $172.31M | $121.72M | $38.42M |
June 30, 2022 | $25.19M | -19.84% | $0.965 | 35.44M | $34.20M | $47.38M | $38.37M |
March 31, 2022 | $31.43M | 28.82% | $1.75 | 33.74M | $59.04M | $66.43M | $38.81M |
December 31, 2021 | $24.40M | -76.59% | $2.29 | 29.00M | $66.40M | $81.79M | $39.78M |
September 30, 2021 | $104.21M | -11.04% | $5.29 | 26.61M | $140.76M | $76.39M | $39.84M |
June 30, 2021 | $117.14M | 13.15% | $6.5 | 26.53M | $172.43M | $95.16M | $39.88M |
March 31, 2021 | $103.53M | 15.73% | $8.61 | 20.75M | $178.67M | $114.94M | $39.81M |
December 31, 2020 | $89.46M | 14.49% | $6.43 | 20.17M | $129.72M | $78.71M | $38.45M |
September 30, 2020 | $78.13M | -29.44% | $6.77 | 20.09M | $135.98M | $88.81M | $30.97M |
June 30, 2020 | $110.74M | -1.96% | $9.32 | 20.03M | $186.70M | $103.74M | $27.78M |
March 31, 2020 | $112.95M | 54.91% | $10 | 20.01M | $200.14M | $115.05M | $27.87M |
December 31, 2019 | $72.92M | -44.70% | $10.7 | 16.47M | $176.19M | $126.18M | $22.91M |
September 30, 2019 | $131.84M | -10.00% | $12.71 | 14.56M | $185.08M | $76.25M | $23.01M |
June 30, 2019 | $146.49M | 367.48% | $15.75 | 13.18M | $207.54M | $90.18M | $29.13M |
March 31, 2019 | $31.34M | 2878.96% | $17.96 | 1.72M | $30.86M | $22.30M | $22.78M |
December 31, 2018 | $1.05M | -113.44% | $13.92 | 1.72M | $23.91M | $30.75M | $7.89M |
September 30, 2018 | $-7.83M | -159.42% | $9.3 | 2.39M | $22.19M | $40.75M | $10.73M |
June 30, 2018 | $13.18M | -95.21% | $21.78 | 2.38M | $51.92M | $49.94M | $11.19M |
March 31, 2018 | $275.22M | 1251.52% | $137.34 | 2.38M | $327.20M | $64.00M | $12.02M |
December 31, 2017 | $20.36M | -85.25% | $76.56 | 1.11M | $84.92M | $76.79M | $12.24M |
September 30, 2017 | $138.06M | 136.77% | $84.18 | 1.80M | $151.80M | $26.25M | $12.52M |
June 30, 2017 | $58.31M | -38.23% | $84.18 | 928.01K | $78.12M | $32.50M | $12.69M |
March 31, 2017 | $94.40M | 4.45% | $84.18 | 928.01K | $78.12M | $3.88M | $20.15M |
December 31, 2016 | $90.37M | 170.38% | $84.18 | 928.01K | $78.12M | $3.04M | $15.29M |
March 31, 2016 | $33.43M | - | $84.18 | 397.07K | $33.43M | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.